# Fundly.ai

> B2B pharma commerce, payments, and embedded credit for India’s retail and distributor supply chain.

## Why it is interesting

September 8, 2026 ~$4M equity led by Accel and Multiply Ventures plus ~$0.9M venture debt (~$4.9M total) — Accel doubling down after a 2023 $3M seed as Fundly expands from supply-chain finance into full-stack pharma distribution rails.

## Profile

- **Latest funding:** Seed — $3M (2023)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $3M
- **Stage:** series-a
- **Status:** private
- **Industries:** fintech, marketplace, healthtech
- **Coverage:** full
- **Last updated:** 2026-09-08
- **Latest funding investors:** Accel, Multiply Ventures

## Key facts

- ~$4M equity led by Accel + Multiply Ventures; ~$0.9M venture debt (~$4.9M total) — Sep 8, 2026
- Builds on Accel-led $3M seed (2023)
- Product stack: B2B commerce + payments + embedded working-capital credit for pharma retail/distribution

## Funding history

- Equity + venture debt · ~$4.9M ($4M equity + $0.9M debt) · September 2026
  Source: https://www.indianstartuptimes.com/investment/fundly-ai-raises-4-million-to-expand-b2b-pharma-distribution-platform/
- Seed · $3M · 2023
  Source: https://www.indianstartuptimes.com/investment/fundly-ai-raises-4-million-to-expand-b2b-pharma-distribution-platform/

## Related articles

- https://venturecapitaltracker.com/2026-fundly-ai-4m-accel-multiply-pharma-rails
- https://venturecapitaltracker.com/2026-september-7-8-investment-news-saf-voice-tenders-industrial

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** September 8, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/fundly-ai